Effects of aprotinin on short-term and long-term outcomes after coronary artery bypass grafting surgery.

[1]  Shengshou Hu,et al.  A comparison before and after aprotinin was suspended in cardiac surgery: different results in the real world from a single cardiac center in China. , 2009, The Journal of thoracic and cardiovascular surgery.

[2]  G. Gravlee.  Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death , 2009 .

[3]  R. Martineau,et al.  A comparison of aprotinin and lysine analogues in high-risk cardiac surgery. , 2008, The New England journal of medicine.

[4]  N. Freemantle,et al.  Bleeding in cardiac surgery: the use of aprotinin does not affect survival. , 2008, The Journal of thoracic and cardiovascular surgery.

[5]  R. Hetzer,et al.  High-dose aprotinin effectively reduces blood loss during on-pump coronary artery bypass grafting with bivalirudin anticoagulation. , 2008, The Journal of thoracic and cardiovascular surgery.

[6]  W. White,et al.  The effect of aprotinin on outcome after coronary-artery bypass grafting. , 2008, The New England journal of medicine.

[7]  K. Zacharowski,et al.  Effect of aprotinin on renal dysfunction in patients undergoing on-pump and off-pump cardiac surgery: a retrospective observational study , 2008, The Lancet.

[8]  M. Kertai,et al.  Aprotinin and perioperative complications in cardiac surgery. , 2007, The Journal of cardiovascular surgery.

[9]  S. Reeves,et al.  Aprotinin in Cardiac Surgery: A Review of Conventional and Novel Mechanisms of Action , 2007, Anesthesia and analgesia.

[10]  A. Hoeft,et al.  Mortality associated with aprotinin during 5 years following coronary artery bypass graft surgery. , 2007, JAMA.

[11]  J. Dunning,et al.  Does use of aprotinin decrease the incidence of stroke and neurological complications in adult patients undergoing cardiac surgery? , 2006, Interactive cardiovascular and thoracic surgery.

[12]  S. Body,et al.  Full-Dose Aprotinin Use in Coronary Artery Bypass Graft Surgery: An Analysis of Perioperative Pharmacotherapy and Patient Outcomes , 2006, Anesthesia and analgesia.

[13]  I. C. Tudor,et al.  The risk associated with aprotinin in cardiac surgery. , 2006, The New England journal of medicine.

[14]  B. Griffith,et al.  Aprotinin shows both hemostatic and antithrombotic effects during off-pump coronary artery bypass grafting. , 2006, The Annals of thoracic surgery.

[15]  H. Lazar,et al.  Aprotinin Decreases Ischemic Damage During Coronary Revascularization , 2005, Journal of cardiac surgery.

[16]  S. Chu,et al.  Relationship of international normalized ratio to bleeding and thromboembolism rates in Taiwanese patients receiving vitamin K antagonist after mechanical valve replacement. , 2005, Journal of the Formosan Medical Association = Taiwan yi zhi.

[17]  T. Treasure,et al.  Effect of aprotinin on clinical outcomes in coronary artery bypass graft surgery: A systematic review and meta-analysis of randomized clinical trials , 2005 .

[18]  F. Sellke,et al.  Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. , 2004, The Journal of thoracic and cardiovascular surgery.

[19]  C. Mestres,et al.  Racial and ethnic differences in warfarin response. , 2004, The Journal of heart valve disease.

[20]  N. Sattar,et al.  Specific elevation in plasma tissue plasminogen activator antigen concentrations in South Asians relative to Europeans , 2003, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[21]  J. Murkin.  Attenuation of neurologic injury during cardiac surgery. , 2001, The Annals of thoracic surgery.

[22]  P. Grant,et al.  Impaired fibrinolysis and increased fibrinogen levels in South Asian subjects. , 2001, Atherosclerosis.

[23]  N. Hayashida,et al.  Effects of minimal-dose aprotinin on coronary artery bypass grafting. , 1997, Journal of Thoracic and Cardiovascular Surgery.

[24]  H. Teufelsbauer,et al.  Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. , 1994, The Journal of thoracic and cardiovascular surgery.

[25]  K. M. Taylor,et al.  EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY , 1987, The Lancet.